Evidence Hub

Acute sildenafil administration decreases the susceptibility to induced atrial fibrillation in sheep

Madders GWP, Denham NC, Hutchings DC, Smith CER, Whitley AS, Obeidat M, Trafford AW, Pearman CM et al.

Journal of molecular and cellular cardiology plus, 2026

Abstract

Sildenafil has been shown to decrease ventricular arrhythmias. We investigated whether sildenafil could similarly decrease atrial fibrillation (AF) burden through direct effects on atrial electrophysiology. In vivo electrophysiological studies were performed in 12 anaesthetised sheep before and after 10 mg intravenous sildenafil. Sildenafil decreased AF vulnerability by decreasing both AF incidence and duration. The antiarrhythmic actions of sildenafil were associated with increases in atrial effective refractory period and atrial wavelength, together with a decrease in alternans magnitude which were expected to limit both AF duration and incidence respectively. The antiarrhythmic effects of acute sildenafil should be confirmed in man.

How strong is the evidence?

Evidence Hub reads this as a report, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free